Drug information for ZELAPAR

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
TABLET, ORALLY DISINTEGRATING; ORAL	1.25MG	Prescription	(Reference Drug)	SELEGILINE HYDROCHLORIDE	Selegiline	VALEANT PHARM INTL	21479 2009-01-15 Review 2009-01-06 Label 2009-01-06 Label 2009-01-06 Letter 2009-01-06 Letter 2006-06-20 Label 2006-06-20 Letter

Drug Adverse Effects information for ZELAPAR

Role code	Indications	Reaction	# Reports
C	OSTEOPOROSIS	ATRIAL FIBRILLATION	1
C	OSTEOPOROSIS	BLOOD CALCIUM INCREASED	1
C	OSTEOPOROSIS	BLOOD ELECTROLYTES DECREASED	1
C	OSTEOPOROSIS	BLOOD POTASSIUM DECREASED	1
C	OSTEOPOROSIS	BONE PAIN	1
C	OSTEOPOROSIS	CARDIAC FAILURE CONGESTIVE	1
C	OSTEOPOROSIS	CONTUSION	1
C	OSTEOPOROSIS	DRY MOUTH	1
C	OSTEOPOROSIS	FALL	1
C	OSTEOPOROSIS	FATIGUE	1
C	OSTEOPOROSIS	HAND FRACTURE	1
C	OSTEOPOROSIS	HEART VALVE INCOMPETENCE	1
C	OSTEOPOROSIS	INFECTION	1
C	OSTEOPOROSIS	INSOMNIA	1
C	OSTEOPOROSIS	MOUTH INJURY	1
C	OSTEOPOROSIS	MUSCULOSKELETAL DISCOMFORT	1
C	OSTEOPOROSIS	NAUSEA	1
C	OSTEOPOROSIS	PAIN	1
C	OSTEOPOROSIS	PAIN IN EXTREMITY	1
C	OSTEOPOROSIS	PRODUCT TASTE ABNORMAL	1
C	OSTEOPOROSIS	RIB FRACTURE	1
C	OSTEOPOROSIS	TOOTH FRACTURE	1
C	OSTEOPOROSIS	UPPER LIMB FRACTURE	1
C	OSTEOPOROSIS	WALKING AID USER	1
C	OSTEOPOROSIS	WEIGHT DECREASED	1
C	OSTEOPOROSIS	WRIST FRACTURE	1
C	PARKINSON'S DISEASE	CHROMATURIA	5
C	PARKINSON'S DISEASE	DYSSTASIA	5
C	PARKINSON'S DISEASE	GAIT DISTURBANCE	5
C	PARKINSON'S DISEASE	MOBILITY DECREASED	5
C	PARKINSON'S DISEASE	MUSCLE RIGIDITY	5
C	PARKINSON'S DISEASE	PARKINSON'S DISEASE	5
C	PARKINSON'S DISEASE	PELVIC FRACTURE	5
C	PARKINSON'S DISEASE	TREMOR	5

Ads by Google